Utilize este identificador para referenciar este registo: https://hdl.handle.net/10316/95895
Título: Re-Use of Caco-2 Monolayers in Permeability Assays—Validation Regarding Cell Monolayer Integrity
Autor: Pires, Cristiana L.
Praça, Catarina 
Martins, Patrícia A. T.
Batista de Carvalho, Ana L. M. 
Ferreira, Lino 
Catarro, Maria Paula M. Marques 
Moreno, Maria João 
Palavras-chave: Caco-2 cells; High-throughput; Intestinal permeability; Lucifer yellow; Tight junctions
Data: 2021
Editora: MDPI
Projeto: UIDB/00070/2020 
NEUROATLANTIC/EAPA_791/2018 
0624_2IQBIONEURO_6_E 
SFRH/BD/138873/2018 
UIDB/00313/2020 
UIDP/00313/2020 
PT2020-PTDC/QUI-OUT/29373/2017 
PT2020-PTDC/DTP-FTO/2784/2014 
Título da revista, periódico, livro ou evento: Pharmaceutics
Volume: 13
Número: 10
Resumo: Caco-2 monolayers are a common in vitro model used to evaluate human intestinal absorption. The reference protocol requires 21 days post-seeding to establish a stable and confluent cell monolayer, which is used in a single permeability assay during the period of monolayer stability (up to day 30). In this work, we characterize variations in the tightness of the cell monolayer over the stable time interval and evaluate the conditions required for their re-use in permeability assays. The monolayer integrity was assessed through TEER measurements and permeability of the paracellular marker Lucifer Yellow (LY), complemented with nuclei and ZO-1 staining for morphological studies and the presence of tight junctions. Over 150 permeability assays were performed, which showed that manipulation of the cell monolayer in the permeability assay may contribute significantly to the flux of LY, leading to Papp values that are dependent on the sampling duration. The assay also leads to a small decrease in the cell monolayer TEER, which is fully recovered when cell monolayers are incubated with culture media for two full days. When this procedure is followed, the cell monolayers may be used for permeability assays on days 22, 25, and 28, triplicating the throughput of this important assay. © 2021 by the authors. Licensee MDPI, Basel, Switzerland.
URI: https://hdl.handle.net/10316/95895
ISSN: 1999-4923
DOI: 10.3390/pharmaceutics13101563
Direitos: openAccess
Aparece nas coleções:I&D CQC - Artigos em Revistas Internacionais
I&D CNC - Artigos em Revistas Internacionais
I&D QFM-UC - Artigos em Revistas Internacionais
FMUC Medicina - Artigos em Revistas Internacionais
FCTUC Ciências da Vida - Artigos em Revistas Internacionais

Ficheiros deste registo:
Ficheiro Descrição TamanhoFormato
pharmaceutics-13-01563-v2.pdf4.4 MBAdobe PDFVer/Abrir
Mostrar registo em formato completo

Citações SCOPUSTM   

16
Visto em 18/mar/2024

Citações WEB OF SCIENCETM

16
Visto em 2/fev/2024

Visualizações de página

268
Visto em 26/mar/2024

Downloads

194
Visto em 26/mar/2024

Google ScholarTM

Verificar

Altmetric

Altmetric


Este registo está protegido por Licença Creative Commons Creative Commons